• SENSEX 74,315.61
    1,533.72 (+2.11%)
  • BANKNIFTY 55,810.50
    494.50 (+0.89%)
Back

Corporate News

Ajanta Pharma submitted a regulatory certificate to BSE and NSE for the September quarter
07-Oct-2026, 02:40

Ajanta Pharma Limited submitted a certificate to the BSE Limited and National Stock Exchange of India under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended September 30, 2026, as confirmed by MUFG Intime India Private Limited, formerly Link Intime India Private Limited, the company’s registrar and share transfer agent.